Overview Dividends

(CHRW) CH Robinson Worldwide - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US12541W2098

Freight, Logistics, Brokerage, Produce, Forwarding

Air Freight & Logistics
Market Cap in USD: 18,018m
IPO / Inception: 1997-10-15
Return 12m vs S&P 500: 23.3%

Dividends

Dividend Yield 1.59%
Yield on Cost 5y 3.05%
Yield CAGR 5y 4.79%
Payout Consistency 98.5%
Payout Ratio 49.1%
Risk via 10d forecast
Volatility 28.1%
Value at Risk 5%th 39.0%
Relative Tail Risk -15.51%
Reward TTM
Sharpe Ratio 1.10
Alpha 36.07
CAGR/Max DD 0.65
Character TTM
Hurst Exponent 0.817
Beta 0.654
Beta Downside 0.790
Drawdowns 3y
Max DD 33.50%
Mean DD 10.89%
Median DD 9.88%

Description: CHRW CH Robinson Worldwide October 30, 2025

C.H. Robinson Worldwide Inc. (NASDAQ:CHRW) is a global logistics provider that operates two primary segments: North American Surface Transportation and Global Forwarding. The firm brokers truckload, less-than-truckload (LTL), intermodal, air, and ocean freight, while also offering customs brokerage, managed-service warehousing, and door-to-door solutions.

Beyond traditional freight brokerage, CHRW runs the Robinson Fresh business, sourcing and distributing fresh produce to grocery chains, restaurants, and food-service distributors through a network of independent growers. This vertical adds a perishable-goods revenue stream that is relatively insulated from macro-economic cycles.

Key operational metrics from recent filings show FY 2023 revenue of roughly $16.5 billion, an adjusted EBITDA margin near 7 %, and a 5 % year-over-year increase in intermodal volume-a segment that benefits from rail capacity constraints and higher rail-to-truck rate differentials. The company’s growth is also tied to broader sector drivers such as sustained e-commerce demand, ongoing truck-driver shortages, and volatile freight-rate indexes that can boost brokerage fees.

For a deeper quantitative dive, you might explore ValueRay’s detailed financial model for CHRW.

Piotroski VR‑10 (Strict, 0-10) 4.5

Net Income (600.1m TTM) > 0 and > 6% of Revenue (6% = 990.3m TTM)
FCFTA 0.16 (>2.0%) and ΔFCFTA 12.17pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 6.68% (prev 6.18%; Δ 0.50pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.17 (>3.0%) and CFO 877.0m > Net Income 600.1m (YES >=105%, WARN >=100%)
Net Debt (1.37b) to EBITDA (977.0m) ratio: 1.40 <= 3.0 (WARN <= 3.5)
Current Ratio 1.59 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (121.4m) change vs 12m ago 0.19% (target <= -2.0% for YES)
Gross Margin 8.30% (prev 6.95%; Δ 1.34pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 304.5% (prev 316.4%; Δ -11.94pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 5.97 (EBITDA TTM 977.0m / Interest Expense TTM 146.7m) >= 6 (WARN >= 3)

Altman Z'' 8.07

(A) 0.21 = (Total Current Assets 2.99b - Total Current Liabilities 1.88b) / Total Assets 5.23b
(B) 1.15 = Retained Earnings (Balance) 6.01b / Total Assets 5.23b
warn (B) unusual magnitude: 1.15 — check mapping/units
(C) 0.16 = EBIT TTM 876.3m / Avg Total Assets 5.42b
(D) 1.76 = Book Value of Equity 5.95b / Total Liabilities 3.37b
Total Rating: 8.07 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 63.12

1. Piotroski 4.50pt
2. FCF Yield 4.43%
3. FCF Margin 5.20%
4. Debt/Equity 0.81
5. Debt/Ebitda 1.40
6. ROIC - WACC (= 14.28)%
7. RoE 33.82%
8. Rev. Trend -86.05%
9. EPS Trend -35.25%

What is the price of CHRW shares?

As of December 13, 2025, the stock is trading at USD 157.09 with a total of 1,298,550 shares traded.
Over the past week, the price has changed by -0.08%, over one month by +3.09%, over three months by +19.11% and over the past year by +40.75%.

Is CHRW a buy, sell or hold?

CH Robinson Worldwide has received a consensus analysts rating of 3.81. Therefore, it is recommended to buy CHRW.
  • Strong Buy: 11
  • Buy: 2
  • Hold: 11
  • Sell: 1
  • Strong Sell: 1

What are the forecasts/targets for the CHRW price?

Issuer Target Up/Down from current
Wallstreet Target Price 152.5 -2.9%
Analysts Target Price 152.5 -2.9%
ValueRay Target Price 179.6 14.3%

CHRW Fundamental Data Overview December 11, 2025

Market Cap USD = 18.02b (18.02b USD * 1.0 USD.USD)
P/E Trailing = 30.8745
P/E Forward = 26.5957
P/S = 1.0917
P/B = 9.7593
P/EG = 2.1597
Beta = 0.906
Revenue TTM = 16.50b USD
EBIT TTM = 876.3m USD
EBITDA TTM = 977.0m USD
Long Term Debt = 1.18b USD (from longTermDebt, last quarter)
Short Term Debt = 72.2m USD (from shortTermDebt, last quarter)
Debt = 1.50b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.37b USD (from netDebt column, last quarter)
Enterprise Value = 19.38b USD (18.02b + Debt 1.50b - CCE 136.8m)
Interest Coverage Ratio = 5.97 (Ebit TTM 876.3m / Interest Expense TTM 146.7m)
FCF Yield = 4.43% (FCF TTM 857.7m / Enterprise Value 19.38b)
FCF Margin = 5.20% (FCF TTM 857.7m / Revenue TTM 16.50b)
Net Margin = 3.64% (Net Income TTM 600.1m / Revenue TTM 16.50b)
Gross Margin = 8.30% ((Revenue TTM 16.50b - Cost of Revenue TTM 15.14b) / Revenue TTM)
Gross Margin QoQ = 8.62% (prev 8.65%)
Tobins Q-Ratio = 3.71 (Enterprise Value 19.38b / Total Assets 5.23b)
Interest Expense / Debt = 6.29% (Interest Expense 94.5m / Debt 1.50b)
Taxrate = 20.58% (42.2m / 205.2m)
NOPAT = 695.9m (EBIT 876.3m * (1 - 20.58%))
Current Ratio = 1.59 (Total Current Assets 2.99b / Total Current Liabilities 1.88b)
Debt / Equity = 0.81 (Debt 1.50b / totalStockholderEquity, last quarter 1.86b)
Debt / EBITDA = 1.40 (Net Debt 1.37b / EBITDA 977.0m)
Debt / FCF = 1.59 (Net Debt 1.37b / FCF TTM 857.7m)
Total Stockholder Equity = 1.77b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.48% (Net Income 600.1m / Total Assets 5.23b)
RoE = 33.82% (Net Income TTM 600.1m / Total Stockholder Equity 1.77b)
RoCE = 29.63% (EBIT 876.3m / Capital Employed (Equity 1.77b + L.T.Debt 1.18b))
RoIC = 22.44% (NOPAT 695.9m / Invested Capital 3.10b)
WACC = 8.17% (E(18.02b)/V(19.52b) * Re(8.43%) + D(1.50b)/V(19.52b) * Rd(6.29%) * (1-Tc(0.21)))
Discount Rate = 8.43% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.75%
[DCF Debug] Terminal Value 80.20% ; FCFE base≈609.8m ; Y1≈752.3m ; Y5≈1.28b
Fair Price DCF = 171.4 (DCF Value 20.25b / Shares Outstanding 118.1m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -35.25 | EPS CAGR: -5.63% | SUE: 0.60 | # QB: 0
Revenue Correlation: -86.05 | Revenue CAGR: -11.36% | SUE: -0.56 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.31 | Chg30d=+0.004 | Revisions Net=+10 | Analysts=15
EPS next Year (2026-12-31): EPS=5.98 | Chg30d=+0.025 | Revisions Net=+24 | Growth EPS=+19.8% | Growth Revenue=+3.1%

Additional Sources for CHRW Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle